Gynecologic Track News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gynecologic Track. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gynecologic Track Today - Breaking & Trending Today

Atezolizumab Plus Bevacizumab and Chemo Improves Survival in Metastatic or Recurrent Cervical Cancer

Published: November 4, 2023

The addition of atezolizumab to bevacizumab and chemotherapy resulted in a significant improvement in progression-free survival and overall survival vs standard treatment with bevacizumab and chemotherapy in patients with metastatic, persistent, or recurrent cervical cancer.

Source: onclive.com

Related Topics:

Israel GeneralComunidad Autonoma De CatalunaSri LankaNational Cancer InstituteHebron Institute Of OncologyGynecologic Oncology GroupGynecologic Cancer Program At VallCervical Cancer Committee In Gynecologic IntergroupGynecologic Cancer ProgramHebron InstituteGynecologic TrackCervical Cancer CommitteeGynecologic Cancer IntergroupNational CancerThe Addition Of Atezolizumab To Bevacizumab And ChemotherapyPatients With MetastaticR Recurrent Cervical CancerBeatcc TrialAna OakninValld Hebron Institute Of Oncology